Red cell distribution width (RDW) has been associated with heart failure (HF) hospitalization in the general population, but the correlation to HF hospitalization in patients with hypertrophic cardiomyopathy (HCM) is unclear.
H ypertrophic cardiomyopathy (HCM) is a genetic cardiac disease that is characterized by cardiomyocyte hypertrophy, myofibrillar disarray, and interstitial fibrosis, resulting in cardiac remodeling and progressive left ventricular (LV) systolic dysfunction, and eventually progressing into heart failure (HF). 1) Red cell distribution width (RDW) is a measure of anisocytosis or variation in the volume of circulating erythrocytes and is easily available as part of a standard complete blood cell count.
2) RDW is part of routine haematology laboratory tests and is a useful indicator for differentiation and classification of anaemia; high RDW reflects an elevated reticulocyte level because of the possibility of iron deficiency, hemolytic anemia, or folate and vitamin B deficiency. Recent studies have reported a strong independent association between RDW and HF, coronary disease, and myocardial infarctions. [3] [4] [5] Borné, et al. reported RDW was associated with risk of HF in subjects from the general population without a history of HF. 6) However, no study has assessed RDW as an independent predictor of prognosis in HCM patients.
The aim of this study was to evaluate whether high RDW is an independent predictor of HF hospitalization in HCM patients.
Methods
Study population: From November 2014 to March 2016, 141 HCM patients without a history of HF at Renmin Hospital of Wuhan University were enrolled in this study. After excluding 43 patients lost to follow-up, the final population was 98 HCM patients. A diagnosis of HCM was made based on the guidelines of the American College of Cardiology/European Society of Cardiology (ACC/ ESC). 7) These patients were divided into 2 groups according to the RDW cut-off value as follows: RDW < 14%, n =70 (normal RDW group) and RDW !14%, n = 28 (high RDW group). Demographic parameters such as age, gender, underlying disease, blood pressure, and medication use were obtained from their medical records. Laboratory, electrocardiography, and echocardiographic data were also reviewed from their medical records. The present study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of our hospital. Echocardiography data: All patients underwent transthoracic echocardiography (TTE) (Vivid 7; GE) at the time of admission. Standard echocardiographic parameters were obtained by utilizing the techniques recommended by the Yang, ET AL American Society of Echocardiography (ASE) guidelines. 8) Specifically, the LV outflow tract (LVOT) gradient was measured with continuous-wave Doppler in the apical 3-chamber view. LVOT obstruction (LVOTO) was defined as a gradient > 30 mmHg.
7)
Electrocardiogram data: Twelve-lead ECGs (25 mm/second and calibration at amplitude of 1.0 mV/10 mm) were recorded in all patients soon after their admission to the hospital. QT intervals were recorded automatically by the ECG. The corrected QT (QTc) was adjusted for the RR interval using the Bazett formula (QTc = QT/ RR). Measurements and definitions: Red blood cell distribution width (RDW), hemoglobin (Hb), mean corpuscular volume (MCV), and hematocrit (HCT) were determined in all patients at the time of admission. The biochemical laboratory parameters were measured using an automated hematology analyzer (XN-9000, Sysmex Inc., Kobe, Japan). The BNP level was measured by a Dimension-RXL (Dupont Inc., USA). Troponin I was measured with an ADVIA-centaur (Siemens Inc., Germany). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were determined in all patients at the time of admission. Diabetes mellitus (DM) was considered to be present in patients with diabetes controlled by diet, oral hypoglycemic agents, or insulin, as well as in cases discharged from the hospital with a diagnosis of diabetes mellitus and/or prescription of hypoglycemic agents. Hyperlipidemia was defined as either the use of lipid lowering agents, a total serum cholesterol level > 240 mg/dL, or a serum triglyceride level > 200 mg/dL. Follow-up: All subjects were followed up until a first hospitalization due to HF or May 31, 2017, whichever came first. A diagnosis of HF was made based on the guidelines of the American College of Cardiology/American Heart Association (ACC/AHA).
9)
Statistical analysis: Data are expressed as the mean SD or percentages. For variables that showed skewed distributions, descriptive statistics are presented as medians with interquartile ranges. Comparisons of continuous variables were performed using the unpaired t test. Comparisons of categorical variables were analyzed by the chisquare test. A linear regression model was used to correlate RDW with maximum left ventricular wall thickness (MLVWT) and ejection fraction (EF). Receiver operating characteristic (ROC) curve analysis was used to identify the value of RDW predictive of hospitalization for HF. Kaplan-Meier analysis was used to estimate hospitalization for HF free survival, and the differences between the curves were compared using the log-rank test. The prognostic value of each factor was first evaluated by univariate Cox proportional hazard regression analysis. The factors that had P-values < 0.05 in the univariate analysis were entered into a multivariate Cox proportional hazards model to identify the independent predictors. The following explanatory variables were used in the univariate analyses: male gender, Hb, HCV, BNP, MLVWT, LVEF, and RDW. A P < 0.05 was considered to be statistically significant. All statistical analyses were performed using SPSS for Windows version 20 (IBM, NewYork, NY, USA). Table I summarizes the basic characteristics of the 98 HCM patients included in this study. The patients were divided into 2 groups according to the RDW cut-off value as follows: RDW < 14%, n =70 (normal RDW group) and RDW !14%, n = 28 (high RDW group). The age, proportion of diabetes mellitus, proportion of hyperlipidemia, proportion of left ventricular outflow tract obstruction, proportion of ICD, and systolic and diastolic blood pressures did not differ between the 2 groups. Furthermore, QT duration and QTc did not differ between the 2 groups. A higher RDW was associated with lower hemoglobin, hematocrit, and mean corpuscular volume values. Also, the high RDW group had a slightly higher plasma BNP level and a slightly lower left ventricular ejection fraction. In contrast, the plasma high sensitivity C-reactive protein, plasma troponin I, serum creatinine, and albumin levels were not statistically different between the 2 groups. There was slightly greater drug usage in the high RDW group patients, but it was not statistically significant.
Results
The MLVWT in the high RDW group was significantly higher than that in the normal RDW group (18.8 ± 2.9 versus 17.2 ± 3.0, P = 0.018, Table I ). However, there was no correlation between RDW and MLVWT (r 2 = 0.007; P = 0.065, Figure 1A ) in the linear regression analysis. Though weakly, the RDW was negatively correlated with the EF (r 2 = 0.029; P = 0.039, Figure 1B) . The left ventricular ejection fraction (LVEF) in the high RDW group was significantly lower than that in the normal RDW group (57.6 ± 5.0 versus 60.0 ± 4.8, P = 0.036, Table I).
During the mean follow-up period of 16.8 ± 9.0 months, hospitalization for HF was observed in 17 patients (17.3%) in the total population. Patients with a higher RDW had a greater incidence of hospitalization for HF (RDW !14%: 50% versus RDW < 14%: 4.3%, Figure 2A ). HF hospitalization patients had higher RDW than non-HF patients (14.7 ± 1.4% versus 13.0 ± 0.9%, P < 0.001, Figure 2B ).
In the ROC curve analysis, the cut-off value of RDW for predicting hospitalization for HF was 14% (area under the curve 0.86, 95% CI 0.74-0.97) with a sensitivity of 83.2% and specificity of 82.7% (Figure 3 ). The area under the curve (AUC) of LVEF for predicting hospitalization for HF was 0.286, 0.309 for Hb, 0.594 for MLVWT, and 0.703 for BNP. Figure 4 shows the results of KaplanMeier analysis. Patients with RDW !14% had a significantly higher risk of HF hospitalization than those with RDW < 14% (log-rank, P < 0.001).
The results of Cox regression analysis are shown in Table II . On univariate Cox regression analysis, hemoglobin, LVEF, BNP, and RDW were significant predictors of HF hospitalization. On multivariate Cox regression analysis, BNP (HR 1.028, 95% CI 1.011-1.045, P = 0.001) and RDW (HR 1.711, 95% CI 1.042-2.809, P = 0.034) were predictors of HF hospitalization.
Discussion
In the present study, we investigated whether RDW could be an independent predictor of HF hospitalization in HCM patients. The main findings are as follows: (1) High RDW was significantly associated with HF hospitalization in the multivariate Cox regression analysis; (2) A RDW ! 14% predicted HF hospitalization with a sensitivity of 83.2% and a specificity of 82.7%; and (3) HF hospitalization-free survival was significantly lower in the RDW ! 14% group compared with the RDW < 14% group. RDW reflects variability in the size of circulating red cells and is routinely reported by automated laboratory equipment used to perform complete blood counts. Generally, the RDW is often used in the differential diagnosis of anemia. RDW was first found to be a strong independent predictor of greater morbidity and mortality in patients with chronic HF in the CHARM study reported by Felker, et al. 10) Since that study, RDW has been regarded as a predictive marker not only in chronic HF, but also in acute HF, myocardial infarction, coronary disease, and recurrence after catheter ablation for atrial fibrillation. [3] [4] [5] Although RDW has been proven to be associated with HF in the general population, 6) there are limited data regarding the relationship between RDW and HF in HCM patients. Stanzani, et al. 11) recently reported that higher RDW is an independent predictor of cardiac death in cats with HCM and congestive HF. However, no study has assessed RDW as an independent predictor of prognosis in HCM patients. In our assessment of 98 patients with HCM, we found a significant relationship between RDW and poor prognosis in HCM patients; 17 patients (17.3%) were hospitalized due to HF.
RDW PREDICTS PROGNOSIS IN HCM PATIENTS
In the present study, we found that the 17 HF pa- The incidence of hospitalization for HF in the high RDW group was significantly greater than that in the normal RDW group. B: RDW in the HF hospitalization patients was significantly higher than that in the non-HF hospitalization patients.
tients were almost HF with preserved left ventricular ejection fraction (HFpEF; LVEF > 50%). It has been reported that nearly 50% HFpEF occurred in HCM patients with non-LV outflow obstruction (LVOTO) and 20% severe HF was due largely to LVOTO. 12) In our study, only 3 LVOTO (17.6%) were found among the 17 HF hospitalization patients. In this study, we found that a higher RDW was independently correlated with a lower left ventricular ejection fraction (LVEF), which was similar to the results of Al-Najjar, et al. 4 ) Also, an elevated BNP level was found to be linked with increased RDW in this study. Similarly, Fukuta, et al. showed that higher RDW was associated with elevated BNP in patients with coronary artery diseases. 13) Although the mechanism underlying the association between RDW and HF is unclear, several possible explanations can be considered. Firstly, increased activation of the renin-angiotensin system can cause cardiac remodeling and eventually lead to HCM. Increased activation of the renin-angiotensin system and adrenergic hormones could cause elevated RDW with erythropoiesis and reduced cardiac function, resulting in HF. 14) Secondly, inflammatory cytokines have been shown to be predictors of prognosis in HF and proven to play an important role in the incidence of HCM. Proinflammatory cytokines have been found to inhibit erythropoietin-induced erythrocyte matu- Figure 3 . Receiver-operating characteristic (ROC) curve analysis for RDW for predicting HF hospitalization. The optimal cut-off value for predicting HF hospitalization was 14% for RDW. ration, which is reflected in part by an increase in RDW. 15) An activated inflammatory state has been reported to be an important factor in the incidence and maintenance of HF. 16) Thus, this may be a possible mechanism between HF and high RDW in HCM patients. Finally, RDW is used as a method of differential diagnosis of anemia etiology 17) and anemia was reported to play an important role in the association between RDW and HF. 18) However, in our study, RDW was only modestly correlated with serum Hb and MCV, and remained an independent predictor of outcome after adjusting for Hb and MCV. Also, the RDW is considered to be correlated with impaired renal function and malnutrition, 19) but we could not detect a relation between RDW and renal function (serum creatinine) or nutritional state (serum albumin) in this study.
The traditional prognostic factor of plasma BNP level was reported to be an independent predictor for HF hospitalization in HCM patients. Mutlu, et al. 20) reported that a NT-pro-BNP plasma level !1,500 pg/mL detected HCM patients with clinical endpoints with sensitivity and specificity of 83% and 81%, respectively. Surprisingly, the predictive effect of BNP on heart failure is slightly worse than that of RDW in the present study. In this study, RDW !14% predicted HF hospitalization with a sensitivity of 83.2% and specificity of 82.7%, and the AUC was 0.856, and the AUC of BNP was 0.703. Furthermore, in the final model (adjusted for BNP and other covariates of HF hospitalization), the most powerful predictor of HF hospitalization was elevated RDW (HR 1.711, P = 0.034). This result is similar to those of Förhécz, et al. 19) and He, et al. 21) It seems that RDW was a more powerful parameter for predicting HF hospitalization in HCM patients than BNP. It was reported that the level of plasma BNP is independently related to the severity of HF in HCM patients and that plasma BNP was greater in patients with an ejection fraction < 50% than in patients with preserved LV systolic function. 22) In our study, most of the 17 HF hospitalization subjects had preserved LVEF. Therefore, the level of plasma BNP may not be different between HF hospitalization patients and non-HF hospitalization patients. Our results were drawn from a small-sample study, which is a potential limitation to evaluating prognosis, including well-known prognostic factors.
This study has some limitations that should be noted. First, because the size of the study was small and the design retrospective, the findings need to be confirmed in larger populations and prospectively designed studies. Second, the follow-up period was quite short (16.8 ± 9.0 months) and a longer follow-up period is needed. Third, the mechanism underlying this observation is unclear and its determination is largely hampered by the lack of epidemiologic studies demonstrating factors that are associated with anisocytosis. Because RDW is not a therapeutic target, but rather, a marker of disease state or risk, it is important to understand the role of RDW in the pathological processes of HCM progress into HF. Finally, genetic data was not available for these patients. Further study with a larger sample size, including a test of mutation, is warranted, the results of which would be expected to show the correlations among genetic background, RDW, and HF hospitalization in HCM patients.
Conclusions
In conclusion, we identified high RDW as an independent prognostic marker for HF hospitalization in HCM patients. RDW, a largely overlooked variable available to clinicians for most of their patients with HCM, has greater independent association with outcome than many other clinical and laboratory parameters promoted for use in determining a prognosis.
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